{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:31:46Z","timestamp":1783571506216,"version":"3.55.0"},"reference-count":85,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      SAR247799 is a G\u2010protein\u2010biased sphingosine\u20101 phosphate receptor\u20101 (S1P\n                      <jats:sub>1<\/jats:sub>\n                      ) agonist designed to activate endothelial S1P\n                      <jats:sub>1<\/jats:sub>\n                      and provide endothelial\u2010protective properties, while limiting S1P\n                      <jats:sub>1<\/jats:sub>\n                      desensitization and consequent lymphocyte\u2010count reduction associated with higher doses. The aim was to show whether S1P\n                      <jats:sub>1<\/jats:sub>\n                      activation can promote endothelial effects in patients and, if so, select SAR247799 doses for further clinical investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Type\u20102 diabetes patients, enriched for endothelial dysfunction (flow\u2010mediated dilation, FMD &lt;7%;\n                      <jats:italic>n<\/jats:italic>\n                      = 54), were randomized, in 2 sequential cohorts, to 28\u2010day once\u2010daily treatment with SAR247799 (1 or 5 mg in ascending cohorts), placebo or 50 mg sildenafil (positive control) in a 5:2:2 ratio per cohort. Endothelial function was assessed by brachial artery FMD. Renal function, biomarkers and lymphocytes were measured following 5\u2010week SAR247799 treatment (3 doses) to Zucker diabetic fatty rats and the data used to select the doses for human testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The maximum FMD change from baseline\n                      <jats:italic>vs<\/jats:italic>\n                      placebo for all treatments was reached on day 35; mean differences\n                      <jats:italic>vs<\/jats:italic>\n                      placebo were 0.60% (95% confidence interval [CI] \u22120.34 to 1.53%;\n                      <jats:italic>P =<\/jats:italic>\n                      .203) for 1 mg SAR247799, 1.07% (95% CI 0.13 to 2.01%;\n                      <jats:italic>P =<\/jats:italic>\n                      .026) for 5 mg SAR247799 and 0.88% (95% CI \u22120.15 to 1.91%;\n                      <jats:italic>P =<\/jats:italic>\n                      .093) for 50 mg sildenafil. Both doses of SAR247799 were well tolerated, did not affect blood pressure, and were associated with minimal\u2010to\u2010no lymphocyte reduction and small\u2010to\u2010moderate heart rate decrease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These data provide the first human evidence suggesting endothelial\u2010protective properties of S1P\n                      <jats:sub>1<\/jats:sub>\n                      activation, with SAR247799 being as effective as the clinical benchmark, sildenafil. Further clinical testing of SAR247799, at sub\u2010lymphocyte\u2010reducing doses (\u22645 mg), is warranted in vascular diseases associated with endothelial dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bcp.14632","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T16:45:07Z","timestamp":1604076307000},"page":"2303-2320","source":"Crossref","is-referenced-by-count":13,"title":["Endothelial\u2010protective effects of a G\u2010protein\u2010biased sphingosine\u20101 phosphate receptor\u20101 agonist, SAR247799, in type\u20102 diabetes rats and a randomized placebo\u2010controlled patient trial"],"prefix":"10.1111","volume":"87","author":[{"given":"Luc","family":"Bergougnan","sequence":"first","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Andersen","sequence":"additional","affiliation":[{"name":"Profil  Neuss Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Plum\u2010M\u00f6rschel","sequence":"additional","affiliation":[{"name":"Profil  Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Evaristi","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Poirier","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Tardat","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  371 Rue du Professeur Blayac Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Ermer","sequence":"additional","affiliation":[{"name":"Profil  Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Herbrand","sequence":"additional","affiliation":[{"name":"Profil  Neuss Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arrubla","sequence":"additional","affiliation":[{"name":"Profil  Neuss Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Veit","family":"Coester","sequence":"additional","affiliation":[{"name":"Profil  Neuss Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sansone","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Pulmonary diseases and Vascular medicine University Hospital D\u00fcsseldorf  D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-8995","authenticated-orcid":false,"given":"Christian","family":"Heiss","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine University of Surrey  Stag Hill Guildford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Vitse","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  371 Rue du Professeur Blayac Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-7180","authenticated-orcid":false,"given":"Fabrice","family":"Hurbin","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  371 Rue du Professeur Blayac Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Boiron","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Benain","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  371 Rue du Professeur Blayac Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Radzik","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Janiak","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Muslin","sequence":"additional","affiliation":[{"name":"Sanofi US Services  Cambridge MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Hovsepian","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Kirkesseli","sequence":"additional","affiliation":[{"name":"Sanofi R&amp;D  1 Avenue Pierre Brossolette Chilly Mazarin France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Deutsch","sequence":"additional","affiliation":[{"name":"Sanofi US Services  Bridgewater NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-0673","authenticated-orcid":false,"given":"Ashfaq A.","family":"Parkar","sequence":"additional","affiliation":[{"name":"Sanofi US Services  Bridgewater NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.7502"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.042"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.02.082"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04221"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000362992"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104793"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar5551"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071682"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.2855"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2020.106436"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00572.2018"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.233205"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(02)00147-6"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309275"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246273"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"e0192616","DOI":"10.1371\/journal.pone.0192616","article-title":"Type 2 diabetes is associated with loss of HDL endothelium protective functions","author":"Vaisar T","year":"2018","journal-title":"PLoS One"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.307049"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-010-0112-5"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-10-70"},{"issue":"9","key":"e_1_2_10_21_1","first-page":"CR490","article-title":"Plasma sphingosine\u20101\u2010phosphate concentration is reduced in patients with myocardial infarction","volume":"15","author":"Knapp M","year":"2009","journal-title":"Med Sci Monit"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2013.10.001"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309287"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep27594"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-019-0376-2"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.04.038"},{"key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"e0168302","DOI":"10.1371\/journal.pone.0168302","article-title":"Serum\u2010Sphingosine\u20101\u2010phosphate concentrations are inversely associated with atherosclerotic diseases in humans","author":"Soltau I","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"e_1_2_10_28_1","first-page":"546","article-title":"The relationship between pre\u2010infarction angina and serum Sphingosine\u20101\u2010phosphate levels","volume":"30","author":"Kiziltunc E","year":"2014","journal-title":"Acta Cardiol Sin"},{"issue":"5","key":"e_1_2_10_29_1","first-page":"379","article-title":"Serum sphingosine 1 phosphate levels in patients with and without coronary collateral circulation","volume":"34","author":"K\u0131z\u0131ltun\u00e7 E","year":"2018","journal-title":"Acta Cardiol Sin"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.124"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.10.072"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107579"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309441"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328361f822"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV17010"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801214200"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu136"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308435"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16777"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2015.10.009"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.02.005"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.057"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201500064"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0586-1"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909494"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30475-6"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.07.005"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318248deea"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01552.x"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm313"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aax8050"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12951"},{"key":"e_1_2_10_53_1","first-page":"1","article-title":"First\u2010in\u2010human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G\u2010protein\u2010biased Sphingosine\u20101 phosphate receptor\u20101 agonist for endothelial protection","author":"Bergougnan L","year":"2020","journal-title":"Br J Clin Pharm"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2014.924876"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)82380-1"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002270"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02298.x"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.01.059"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.8.1336"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.111.013367"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02139-3"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.10.002"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.02.044"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.01.031"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090217"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-173-41611"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(00)80049-9"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-017-0073-1"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1037"},{"key":"e_1_2_10_70_1","first-page":"S21","volume-title":"The concise guide to pharmacology 2019\/20: G protein\u2010coupled receptors","author":"Alexander SP","year":"2019"},{"key":"e_1_2_10_71_1","article-title":"Mechanisms of endothelial regeneration and vascular repair and their application to regenerative medicine","author":"Evans CE","year":"2020","journal-title":"Am J Pathology"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.921"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.765701"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.10.021"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200108000-00005"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq010"},{"key":"e_1_2_10_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706628"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr348"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs019"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206797"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq340"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01149.x"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1159\/000158635"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp064"},{"key":"e_1_2_10_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2015.13"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.04.001"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14632","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14632","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T13:18:06Z","timestamp":1693574286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1111\/bcp.14632"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14632","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.15.20103101","asserted-by":"object"}]},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]}}}